FDA clears automated insulin pump from Beta Bionics
The FDA announced today that it cleared the Beta Bionics iLet ACE automated insulin pump and iLet dosing decision software.
Stay updated with breaking news from Let Bionic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA announced today that it cleared the Beta Bionics iLet ACE automated insulin pump and iLet dosing decision software.
The FDA has cleared a next-generation insulin pump and software combination that provides greater automation than current "artificial pancreas" systems.
The FDA has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for persons 6 years of age and older with type 1 diabetes.
One-Stop Business and Finance News
Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational devices limited by Federal (or United States) law to investigational use. Not...